Richard Quintiliani
- Pharmacology top 0.1%
- Epidemiology top 0.5%
- Molecular Medicine top 0.1%
- Infectious Diseases top 0.5%
- Clinical Biochemistry top 0.2%
- Co-authors
- David P. NicolauCharles H. NightingaleC H NightingalePatrice CourvalinCollin D. FreemanMelinda K. LacyPaul BelliveauJack Ross
- Topics
- Antibiotics Pharmacokinetics and Efficacy (163 papers)Antibiotic Resistance in Bacteria (81 papers)Pneumonia and Respiratory Infections (53 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Richard Quintiliani
254 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 138
- Pharmacology 3.4k
- Epidemiology 2.6k
- Molecular Medicine 1.9k
- Infectious Diseases 1.9k
- Clinical Biochemistry 1.0k
Countries citing papers authored by Richard Quintiliani
This map shows the geographic impact of Richard Quintiliani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Quintiliani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Quintiliani more than expected).
Fields of papers citing papers by Richard Quintiliani
This network shows the impact of papers produced by Richard Quintiliani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Quintiliani. The network helps show where Richard Quintiliani may publish in the future.
Co-authorship network of co-authors of Richard Quintiliani
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Quintiliani. A scholar is included among the top collaborators of Richard Quintiliani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Quintiliani. Richard Quintiliani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 3 | |
| 3 | 37 | |
| 4 | 6 | |
| 5 | Clinical efficacy of cefepime in pneumonia caused by Pseudomonas aeruginosa | 3 |
| 6 | 6 | |
| 7 | 34 | |
| 8 | 15 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 29 | |
| 12 | 9 | |
| 13 | 7 | |
| 14 | Strategy for developing a safe and cost-effective H2-receptor antagonist program. | 1 |
| 15 | 7 | |
| 16 | 11 | |
| 17 | 4 | |
| 18 | THE EFFECT OF PROTEIN-BINDING ON DRUG DISTRIBUTION INTO INTERSTITIAL FLUID (IF) | 2 |
| 19 | Safety and efficacy of combining obstetric and noninfectious gynecologic hospital patients. | 1 |
| 20 | Further observations on the antimicrobial effects of local anesthetic agents. | 26 |
About Richard Quintiliani
Richard Quintiliani is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 260 papers that have together received 6.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (163 papers), Antibiotic Resistance in Bacteria (81 papers) and Pneumonia and Respiratory Infections (53 papers). The work is most often cited by research in Molecular Medicine (1.9k citations), Applied Microbiology and Biotechnology (703 citations) and Pharmacology (3.4k citations). Richard Quintiliani has collaborated with scholars based in United States, France and Australia. Frequent co-authors include David P. Nicolau, Charles H. Nightingale, C H Nightingale, C H Nightingale, Patrice Courvalin, Collin D. Freeman, Melinda K. Lacy, Paul Belliveau, Jack Ross and Michel Arthur. Their work appears in journals such as JAMA, Annals of Internal Medicine and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.